
|Slideshows|February 2, 2017
Neuro News Roundup: MS Biomarker & Second Stroke
Author(s)Mark L. Fuerst
Three new studies explore preventing secondary stroke, a potential biomarker for MS prediction, and a link between vitamin D and headache.
Advertisement
Three new studies in neurology -- one in stroke, one in headache, and one in multiple sclerosis (MS) -- include: the diabetes drug pioglitazone can help prevent secondary stroke in those with abnormal glucose metabolism; men with low blood levels of vitamin D have a higher risk of frequent headaches; and a biomarker may predict which patients with clinically isolated syndrome (CIS) may develop MS.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Roche Unveils PrevenTRON, a Phase 3 Prevention Trial of Trontinemab in Cognitively Unimpaired Individuals at High Risk of Alzheimer Decline
2
Alzheimer's Association Launches PROTECT-Cog Combination Prevention Trial
3
Sanofi's Oral TREM2 Agonist SAR448851 Advances to Phase 2 TREMHANCE Trial in Early Alzheimer Disease
4
Highlighting Gaps in Testing and Diagnosis for Fragile X Syndrome: Craig A. Erickson, MD
5
















